Showing results (661-670 of 720) with videos related to

Sort By:
Pageof 72
Gastroenterology|October 1, 1995
In vitro transcription/translation assay for the screening of hMLH1 and hMSH2 mutations in familial colon cancerM C Luce, G Marra, D P Chauhan, et al.
JAMA Network Open|June 13, 2024
Well-Child Visits for Early Detection and Management of Maternal Postpartum Hypertensive DisordersFarah H Amro, Kim C Smith, Syed S Hashmi, et al.
American Journal of Obstetrics and Gynecology|April 12, 2023
Three-tiered fetal heart rate interpretation system and adverse neonatal and maternal outcomes: a systematic review and meta-analysisFabrizio Zullo, Daniele Di Mascio, Nandini Raghuraman, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 29, 2025
Parturients with diabetes and associated outcomes with Macrosomic newbornsFabrizio Zullo, Teresa C Logue, Daniele Di Mascio, et al.
Plos One|May 16, 2025
Evaluation of the accuracy of a low-cost external tocodynamometer in a pilot study in MalawiAlex Kortum, Christina Samuel, Theresa Sonka, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 22, 2024
Tartronic Acid as a Potential Inhibitor of Pathological Calcium Oxalate CrystallizationYuan Su, Si Li, Xin Li, et al.
American Journal of Obstetrics & Gynecology MFM|May 26, 2025
Antenatal corticosteroids for patients at risk of late preterm birth: a systematic review and meta-analysis of randomized controlled trialsFabrizio Zullo, Moti Gulersen, Daniele Di Mascio, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 8, 2020
A comparison of placental pathology between small for gestational age infants at < 5 % versus 5-9Adam T Sandlin, Everett F Magann, Songthip T Ounpraseuth, et al.
American Journal of Perinatology|April 28, 2018
PROLONG Clinical Study Protocol: Hydroxyprogesterone Caproate to Reduce Recurrent Preterm BirthSean C Blackwell, Cynthia Gyamfi-Bannerman, Joseph R Biggio, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2019
Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapyVikash P Chauhan, Ivy X Chen, Rong Tong, et al.
Pageof 72